{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T13:19:52Z","timestamp":1788182392017,"version":"build-2803163510"},"reference-count":44,"publisher":"Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,1]]},"abstract":"<jats:p>Viral encephalitis (VE), is a life-threatening neurological disorder marked by inflammation of brain parenchyma, driven by direct viral cytotoxicity and host immune-mediated injury. Globally, its incidence ranges from 1.4 to 13.8 cases per 100,000 individuals annually, with significant morbidity and mortality in endemic regions such as India, among children. Neurotropic viruses including herpes simplex virus (HSV), Japanese encephalitis virus (JEV) and West Nile virus, enter central nervous system via hematogenous or neuronal routes, triggering viral replication, cytokine release and blood\u2013brain barrier disruption, resulting in seizures, cerebral edema and long-term neurological deficits. Current management in neurological intensive care relies on immunity-oriented strategies: Acyclovir as first-line antiviral for HSV and varicella-zoster virus, antiepileptics to control seizures and limit secondary neuronal injury and corticosteroids to modulate harmful neuroinflammation and cerebral edema. Emerging therapies, including novel antivirals (favipiravir, remdesivir, brincidofovir), monoclonal antibodies, cytokine inhibitors (tocilizumab, anakinra) and B-cell\/plasma cell-targeted agents (rituximab, daratumumab), offer promise by simultaneously addressing viral replication and immune dysregulation. Personalized biomarker-guided integrating pathogen-directed and host-targeted therapies may optimize outcomes, reduce neuronal injury and improve recovery. This review underscores the importance of a multidimensional, immunity-oriented treatment paradigm, highlighting both established and emerging strategies to enhance prognosis and long-term neurological functions in patients with viral encephalitis.<\/jats:p>","DOI":"10.36721\/pjps.2026.39.7.199.1","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T10:40:50Z","timestamp":1779360050000},"source":"Crossref","is-referenced-by-count":0,"title":["Immunity-Oriented Drug Strategies For Viral Encephalitis: Acyclovir, Antiepileptics And Corticosteroids In Neurological Intensive Care"],"prefix":"10.36721","author":[{"given":"Liping","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22735","published-online":{"date-parts":[[2026,5,10]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"Al-Obaidi MMJ, Baharom N, Nor Rashid N, Othman I, Shueb RH and Sinniah M (2017). Japanese encephalitis virus disrupts blood\u2013brain barrier and modulates apoptosis proteins in THBMEC cells. Virus Res., 233: 17-28.","DOI":"10.1016\/j.virusres.2017.02.012"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Atanasoff KE, Parsons AJ, Ophir SI, Lurain N, Kraus T, Moran T, Duty JA and Tortorella D (2024). A broadly neutralizing human monoclonal antibody generated from transgenic mice immunized with HCMV particles limits virus infection and proliferation. J Virol., 98(7): e00213-24.","DOI":"10.1128\/jvi.00213-24"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Bai F, Kong KF, Dai J, Qian F, Zhang L and Brown CR (2010). A paradoxical role for neutrophils in the pathogenesis of West Nile virus. J. Infect. Dis., 202(12): 1804-1812.","DOI":"10.1086\/657416"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Beckham JD, Tyler KL, Haller IV, Durrant DM, Phares TW and Madden L (2021). A murine model of dengue virus infection in suckling C57BL\/6 and BALB\/c mice. Anim. Models Exp. Med., 4(1): 16-26.","DOI":"10.1002\/ame2.12145"},{"key":"ref4","unstructured":"Becker K, van Alen S, Idelevich EA, Schleimer N, Seggewi\u00df J, Mellmann A, Kaspar U and Peters G (2018). Plasmid-encoded transferable mecB-mediated methicillin resistance. Antimicrob. Agents Chemother., 62(1): e01510-17."},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Bock M, Schmid B and Lancaster MA (2024). Morphogenetic designs and disease models in central nervous system organoids. Int. J. Mol. Sci., 25(14): 7750.","DOI":"10.3390\/ijms25147750"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Boucher A, Charrel R, Lepiller Q, Salinas S, Andre P and Henneton P (2017). Epidemiology of infectious encephalitis causes in 2016. Med. Mal. Infect., 47(3): 221-235.","DOI":"10.1016\/j.medmal.2017.02.003"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Chan-Tack K, Harrington P, Bensman T, Choi SY, Donaldson E and O\u2019Rear J (2021). Benefit\u2013risk assessment for brincidofovir for the treatment of smallpox. Antiviral Res., 195: 105182.","DOI":"10.1016\/j.antiviral.2021.105182"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Charise G, Soung A, Vollmer LL, Kanmogne M, Last A and Brown T (2019). T cells promote microglia-mediated synaptic elimination and cognitive dysfunction during recovery from neuropathogenic flaviviruses. Nat. Neurosci., 22(8): 1276-1288.","DOI":"10.1038\/s41593-019-0427-y"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Chen Y, Li H, Yang J, Zheng H, Guo L and Li W (2021). A hSCARB2-transgenic mouse model for Coxsackievirus A16 pathogenesis. Virol. J., 18(1): 84.","DOI":"10.1186\/s12985-021-01557-5"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Chen Z, Zhong D and Li G (2019). The role of microglia in viral encephalitis: A review. J Neuroinflammation., 16(1):76.","DOI":"10.1186\/s12974-019-1443-2"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Chou S, Ercolani RJ and Duan D (2018). Antiviral activity of maribavir in combination therapy. Antiviral Res., 157: 128-133.","DOI":"10.1016\/j.antiviral.2018.07.013"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Claudette LP, Scott HJ, Anderson K, Boucher MA, Li R and Nguyen T (2018). Antiviral therapies for herpesviruses: Current agents and new directions. Clin. Ther., 40(8): 1282-1298.","DOI":"10.1016\/j.clinthera.2018.07.006"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Depla JA, Mulder LA, de S\u00e1 RV, Wartel M, Sridhar A and Evers MM (2022). Human brain organoids as models for central nervous system viral infection. Viruses, 14(3): 634.","DOI":"10.3390\/v14030634"},{"key":"ref14","unstructured":"Depla JA, Mulder LA, de S\u00e1 RV, Wartel M, Sridhar A and Evers MM (2023). Human brain microphysiological systems in the study of CNS viral infections. Front. Cell. Neurosci., 17: 1020567."},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Duerlund LS, Nielsen H and Bodilsen J (2025). Current epidemiology of infectious encephalitis: A narrative review. Clin. Microbiol. Infect., 31(4): 515-521.","DOI":"10.1016\/j.cmi.2024.12.025"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"El Helou G and Razonable RR (2019). Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients. Infect. Drug Resist., 12: 1481-1491.","DOI":"10.2147\/IDR.S180908"},{"key":"ref17","unstructured":"Fillatre P, Andre A, Cazals X, Sciarrino S, Martinot M and Cantin G (2017). Enc\u00e9phalite infectieuse: Diagnostic \u00e9tiologique et conduite \u00e0 tenir. Med. Mal. Infect., 47(3): 236-251."},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Fugier E, Morfin F, Thouvenot D, Lina B and Morand P (2014). Resistance of herpes simplex virus to acyclovir: A 10-year survey in France. Antiviral Res., 111: 36-41.","DOI":"10.1016\/j.antiviral.2014.08.013"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Gao Q, Bao L, Mao H, Wang L, Xu K, Yang M, Li Y, Zhu L, Wang N, Lv Z, Gao H, Ge X, Kan B, Hu Y, Liu J, Cai F, Jiang D, Yin Y, Qin C and Li J (2020). Development of an inactivated vaccine candidate for SARS-CoV-2. Science, 369(6499): 77-81.","DOI":"10.1126\/science.abc1932"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Garber C, Soung A, Vollmer LL, Kanmogne M and Brown T (2019). T cells promote microglia-mediated synaptic elimination. Nat. Neurosci., 22(8): 1276-1288.","DOI":"10.1038\/s41593-019-0427-y"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Griffiths P and Reeves M (2021). Pathogenesis of human cytomegalovirus in the immunocompromised host. Nat. Rev. Microbiol., 19(12): 759-773.","DOI":"10.1038\/s41579-021-00582-z"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Gundamraj VS and Hasbun R (2023). Viral meningitis and encephalitis: An update. Curr. Opin. Infect. Dis., 36(3): 177-185.","DOI":"10.1097\/QCO.0000000000000922"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Hidayat A, Md Norefrina Shafinaz NN, Nazlina I, Rahman MA, Tan WL and Ahmad N (2013). Phenotypic and genotypic characterization of acyclovir-resistant HSV-1. Antiviral Res., 100(2): 306-313.","DOI":"10.1016\/j.antiviral.2013.09.008"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Ibrahim AM, Kallas EG, Arnal A, Lopez-Lopez MJ, Perez-Ramirez E and Rico-Sanchez A (2025). Epidemiology and surveillance of West Nile virus in the Mediterranean Basin during 2010\u20132023. Curr. Res. Parasitol. Vector-Borne Dis., 7: 100277.","DOI":"10.1016\/j.crpvbd.2025.100277"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Joseph O, Enose-A A, Lavi N, Harel A and Steiner I (2017). Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals. J. Neurovirol., 23(1): 625-639.","DOI":"10.1007\/s13365-016-0473-0"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Kalil Alves de Lima L, Rustenhoven J and Kipnis J (2020). Meningeal immunity and its function in maintenance of the central nervous system in health and disease. Annu. Rev. Immunol., 38: 597-620.","DOI":"10.1146\/annurev-immunol-102319-103410"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Karamitros T, Magiorkinis E, Pliaka V, Beloukas A and Skoura L (2016). De novo assembly of the herpes simplex virus genome. PLoS One, 11: e0157600.","DOI":"10.1371\/journal.pone.0157600"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Kimberlin DW, Whitley RJ, Ramers C, Lantos PM and Cantey JB (2024). Outcome and sequelae of infectious encephalitis. J. Clin. Neurol., 20(1): 23-36.","DOI":"10.3988\/jcn.2023.0240"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Le-Vinh B, Ducastelle-Lepretre S, Gautier-Veyret E, Morfin F and Foulongne V (2019). UL23 and UL30 characterization of HSV-1 strains. Antiviral Res., 168: 114-120.","DOI":"10.1016\/j.antiviral.2019.05.012"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Leung PYM, Tran T, Testro A, Paizis K, Kwong J and Whitlam JB (2019). Ganciclovir-resistant post-transplant cytomegalovirus infection due to combined deletion mutation at codons 595\u2013596 of the UL97 gene. Transpl. Infect. Dis., 21(6): e13168.","DOI":"10.1111\/tid.13168"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Li M, Ostermann PN and Mulder LA (2024). Human brain organoids: Trends, evolution and remaining challenges. Neural Regen. Res., 19(11): 2387-2399.","DOI":"10.4103\/1673-5374.390972"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Looker KJ, Magaret AS, Turner KME, Vickerman P and Newman LM (2017). Global and regional incidence of neonatal herpes. Lancet Glob. Health, 5(3): e300-e309.","DOI":"10.1016\/S2214-109X(16)30362-X"},{"key":"ref33","unstructured":"Lopes Pinheiro MA, Kooij G, Mizee MR, Kamermans A, Enzmann G, Lyck R, Schwaninger M, Engelhardt B and de Vries HE (2020). Meningeal immunity in central nervous system health and disease. Annu. Rev. Immunol., 38: 597-620."},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Marcocci ME, Caccuri F, Fiorentini S, Palamara AT and Nencioni L (2022). Forty years after the registration of acyclovir: Do we need new anti-herpetic drugs? Int. J. Mol. Sci., 23(7): 3431.","DOI":"10.3390\/ijms23073431"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Marrazzo P, Cricca M and Nastasi C (2021). Are organoid models an invaluable contribution to Zika virus research? Pathogens, 10(10): 1233.","DOI":"10.3390\/pathogens10101233"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Perera MR, Wills MR and Sinclair JH (2021). Human cytomegalovirus antivirals and strategies to target the latent reservoir. Viruses, 13(5): 817.","DOI":"10.3390\/v13050817"},{"key":"ref37","unstructured":"Reed C, Smith DR, Alcorn K, Rachal E and Hartman AL (2019). Neutrophil and macrophage influx in lethal Rift Valley fever encephalitis. PLoS Pathog., 15(6): e1001234."},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Sacks CA, Spotswood LS, Hall CM, Williams G and Thompson RF (2011). Acyclovir and hydrocortisone cream for recurrent cold sores. Virus Adapt. Treat., 3: 1-6.","DOI":"10.2147\/VAAT.S7748"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Soria B, Deback C, Agut H and Boutolleau D (2010). Genotypic characterization of UL23 thymidine kinase and UL30 DNA polymerase of clinical isolates of herpes simplex virus: natural polymorphism and mutations associated with resistance to antivirals. Antimicrob. Agents Chemother., 54(11): 4833-4842.","DOI":"10.1128\/AAC.00669-10"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Tippin TK, Morrison ME, Brundage TM and Momm\u00e9ja-Marin H (2016). Brincidofovir is not a substrate for the human organic anion transporter 1: a mechanistic explanation for the lack of nephrotoxicity observed in clinical studies. Ther Drug Monit., 38(6): 777-786.","DOI":"10.1097\/FTD.0000000000000353"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Topalis D, Gillemot S, Snoeck R and Andrei G (2016). Distribution and effects of amino acid changes in drug-resistant \u03b1 and \u03b2 herpesviruses DNA polymerase. Nucleic Acids Res., 44(20):9530-9554.","DOI":"10.1093\/nar\/gkw875"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Wn\u0119k G, Samorek-Salamonowicz E, Bancerz-Kisiel A, Pluta A and Osi\u0144ski Z (2015). Animal herpesviruses and their zoonotic potential for cross-species infection. Ann. Agric. Environ. Med., 22(2): 191-194.","DOI":"10.5604\/12321966.1152063"},{"key":"ref43","unstructured":"Yang D, Li XJ, Tu DZ, Li XL and Wei B (2023). Advances in viral encephalitis: Viral transmission, host immunity and experimental animal models. Zool. Res., 44(3): 525-542."}],"container-title":["Pakistan Journal of Pharmaceutical Sciences"],"original-title":[],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T12:49:31Z","timestamp":1788180571000},"score":1,"resource":{"primary":{"URL":"https:\/\/pjps.pk\/single-article?id=7802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,10]]},"references-count":44,"URL":"https:\/\/doi.org\/10.36721\/pjps.2026.39.7.199.1","relation":{},"ISSN":["1011-601X","3105-9686"],"issn-type":[{"value":"1011-601X","type":"print"},{"value":"3105-9686","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,10]]}}}